Evidence map›Paper›PMID 28079572›Full record

ArticleJournal of addiction medicine

Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE): A Pilot Study in Alcohol-dependent Women.

Anna Persson, Sudie E Back, Therese K Killeen, Kathleen T Brady, Melanie L Schwandt, Markus Heilig, Åsa Magnusson

Registry-linked trialAbstract read
In one paragraph

Article in Journal of addiction medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04760418 (Evaluating the Impact of Trauma, Trauma-Focused Therapy Services, and COVID-19 Among Patients in the University of Kentucky SMART Clinic), which is not on this map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04760418 nacompletednot on this map

Evaluating the Impact of Trauma, Trauma-Focused Therapy Services, and COVID-19 Among Patients in the University of Kentucky SMART Clinic

TypeinterventionalSponsorChristal L BadourRan2021 to 2022Enrolled21ConditionsPTSD, Opioid-use Disorder, Substance Use DisordersArmsConcurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE)
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anna PerssonDepartment of Clinical Neuroscience (AP, AM), Karolinska Institutet; EWA Outpatient Unit (AP, AM), The Stockholm Centre for Dependency Disorders, Stockholm, Sweden; Department of Psychiatry (SEB, TKK, KTB), Medical University of South Carolina; Ralph H. Johnson Veterans Affairs (VA) Medical Center (SEB, KTB), Charleston, SC; Laboratory of Clinical and Experimental Studies (MLS), NIAAA, Bethesda, MD; Department of Clinical and Experimental Medicine (MH), Linköping University, Linköping, Sweden.
Sudie E Back
Therese K Killeen
Kathleen T Brady
Melanie L Schwandt
Markus Heilig
Åsa Magnusson

Funding

Integrating Neurobiology and Neuroimaging into Research on Addiction and PTSDK02DA039229 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BACK, SUDIE E · 2015 to 2019
$779k
NIDA NIH HHS K02 DA039229
6 · The paper itself

Abstract

objectivesPosttraumatic stress disorder (PTSD) and substance use disorders are highly comorbid. Effective treatments are largely lacking. This pilot study evaluated the safety and feasibility of a novel intervention, Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE), in preparation for a randomized controlled trial.

methodsTwenty-two treatment-seeking women with current DSM-IV-TR PTSD and alcohol dependence (AD) were recruited. Participants received COPE. Safety and feasibility were evaluated, as were efficacy-related outcomes: PTSD and depression symptom severity, alcohol use, craving, and dependence severity.

resultsNo adverse events occurred. COPE was implemented in routine clinical practice. Among the assessed women, 95.8% were eligible to participate. Treatment attendance and completion were higher than in previous studies. Post treatment, all efficacy-related outcomes, including PTSD and depression symptom severity, alcohol use, craving, and dependence severity, were significantly reduced.

conclusionsCOPE was safe and feasible to use. Concerns that trauma-focused, exposure-based therapy might promote relapse in this population appear unwarranted. Our findings provide initial evidence suggestive of COPE efficacy for comorbid PTSD and AD in women. These results provide a strong rationale for investigating the efficacy of COPE for comorbid PTSD and AD in women in a randomized controlled trial.

Indexed as

Outcome Assessment, Health CareAdultComorbidityFemaleHumansImplosive TherapyMiddle AgedPilot ProjectsStress Disorders, Post-TraumaticSubstance-Related Disorders

Identifiers

PMID28079572
PMCPMC6223130

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.